Speaker illustration

Doctor Piotr Hamala

Bieganski Hospital, Lodz (Poland)

Member of:

European Society of Cardiology

The prognostic value of myocardial work in patients with chronic alcohol overuse

Event: ESC Congress 2022

Topic: Substance Abuse and Cardiovascular Disease

Session: Substance abuse and cardiovascular disease

Thumbnail

The impact of chronic alcohol overuse on myocardial work

Event: ESC Congress 2022

Topic: Substance Abuse and Cardiovascular Disease

Session: Substance abuse and cardiovascular disease

Thumbnail

The impact of chronic alcohol overuse on right ventricular myocardial strain.

Event: ESC Congress 2021 - The Digital Experience

Topic: Substance Abuse and Cardiovascular Disease

Session: Cardiovascular Disease in Special Populations ePosters

Thumbnail

Pace of progression of aortic stenosis severity in patients with tricuspid and bicuspid valve.

Event: ESC Congress 2020

Topic: Diagnostic Methods

Session: Valvular Heart Disease ePosters

Thumbnail

Impaired left ventricular systolic function in alcohol abusers expressed by both 3D calculated ejection fraction and longitudinal strain by AFI.

Event: ESC Congress 2019

Topic: Substance Abuse and Cardiovascular Disease

Session: Neuropsychiatric disease, substance abuse and the heart

Thumbnail

Baseline planimetry derived aortic valve area as the strongest predictor of aortic stenosis progression.

Event: EuroEcho-Imaging 2018

Topic: Valvular Heart Disease

Session: Echocardiography: Valve Disease

Thumbnail

Left ventricular systolic and diastolic parameters, longitudinal strain and NTproBNP correlate with total alcohol dose in chronic alcohol abusers.

Event: EuroEcho-Imaging 2018

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: HIT Poster session 1

Thumbnail

Alcohol abuse causes impairment of diastolic function and influences left ventricular deformation parameters.

Event: EuroEcho-Imaging 2017

Topic: Other myocardial diseases

Session: Cardiomyopathies

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb